Papa presented the company’s “turnaround plan” for 2025 at J.P. Morgan. “We are focused on first stabilising the company, ...
After hours: January 24 at 7:54:08 p.m. EST ...
NEW FLUORINE-CONTAINING DRUG FROM CHINA: Prusogliptin （ Trade name：Shanzeping, 善泽平）, A novel oral DPP-4 inhibitor ， Developed by by CSPC Pharmaceutical Group Co., Ltd., CHINA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback